UNITED STATES OF AMERICA
The world’s largest market for pharmaceuticals, USA has always been on Torrent Pharma’s strategic radar. Torrent Pharma Inc., our subsidiary, serves the growing need of our products in the market and today we are ranked 10th amongst the US generic Indian Companies.
We have 88 ANDAs approval with 42 approvals in pipeline. We aim to strengthen our position in the market by launching complex generics which include specialty oral solids (Oncology) and value added medicines 505(b)(2) in the coming times.
Torrent has strengthened the US presence through acquisition of Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA, which includes, its first overseas US FDA registered manufacturing facility.